FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer
Stopped early · Phase 2
Conditions studied: Adenocarcinoma of the Gastroesophageal Junction, Gastric Adenocarcinoma, Gastric Cancer
In brief
This randomized phase II trial studies how well fludeoxyglucose F-18 (FDG)/positron emission tomography (PET) directed treatment improves response in patients with stomach or gastroesophageal junction cancer that has not spread past the stomach and is not responding to the usual treatment. PET scans are a different way to take pictures of cancer and can be used to look at how much energy (such as glucose) is being used by the cancer. Using PET scans early to monitor the success of treatment may allow doctors to measure response and change treatment accordingly.
Key facts
- Study ID
- NCT02485834
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 5
- Starts
- 2015-11-12
- Expected to finish
- 2018-08-01
- Last updated by the study team
- 2025-01-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- USC / Norris Comprehensive Cancer Center — Los Angeles, California, United States
- Saint Helena Hospital — St. Helena, California, United States
- Helen F Graham Cancer Center — Newark, Delaware, United States
- Medical Oncology Hematology Consultants PA — Newark, Delaware, United States
- Regional Hematology and Oncology PA — Newark, Delaware, United States
- Christiana Care Health System-Christiana Hospital — Newark, Delaware, United States
- Emory University Hospital Midtown — Atlanta, Georgia, United States
- Emory University/Winship Cancer Institute — Atlanta, Georgia, United States
- Hawaii Cancer Care Inc-POB II — Honolulu, Hawaii, United States
- Queen's Medical Center — Honolulu, Hawaii, United States
- Straub Clinic and Hospital — Honolulu, Hawaii, United States
- Hawaii Cancer Care Inc-Liliha — Honolulu, Hawaii, United States
- Hawaii Oncology Inc-Kuakini — Honolulu, Hawaii, United States
- The Cancer Center of Hawaii-Liliha — Honolulu, Hawaii, United States
- Hawaii Oncology Inc-Pali Momi — ‘Aiea, Hawaii, United States
- Kootenai Cancer Center — Post Falls, Idaho, United States
- John H Stroger Jr Hospital of Cook County — Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center — Chicago, Illinois, United States
- Northwestern Medicine Cancer Center Delnor — Geneva, Illinois, United States
- Northwestern Medicine Cancer Center Warrenville — Warrenville, Illinois, United States
- Memorial Regional Cancer Center Day Road — Mishawaka, Indiana, United States
- Reid Health — Richmond, Indiana, United States
- Memorial Hospital of South Bend — South Bend, Indiana, United States
- Dana-Farber Cancer Institute — Boston, Massachusetts, United States
- Los Angeles County-USC Medical Center — Los Angeles, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.